Machine Learning‐Enhanced Generic Raman Model for Commercial‐Scale Cell Culture Process Monitoring
Biotechnology Journal · 2026
DOI: 10.1002/biot.70309 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biotechnology Journal, 2026. Verfasst von Yunfei Shen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Informatics Institute, School of Pharmacy, Zhejiang University, Hangzhou, China. Hauptthemen laut MEDLINE: Spectrum Analysis, Raman, Machine Learning, Cell Culture Techniques. Die Arbeit nennt 60 Literaturangaben. Gefördert von: the Key Research and Development Program of Zhejiang Province, China.
Abstract (Originalsprache)
Continuous monitoring of therapeutic cell cultures via Raman spectroscopy traditionally relies on product‐specific calibration models, which often fail to generalize across diverse commercial processes when process parameter or cell lines change. To overcome the need for extensive recalibration, an integrated generic Raman modeling framework was developed by aggregating in‐line spectra from four distinct 1500‐L commercial Chinese hamster ovary fed‐batch processes. Fifteen combinations of regression algorithms and feature selection strategies were first evaluated under sample‐level splitting, and representative pipelines were subsequently assessed through repeated batch‐level validation splits. A Support Vector Machine combined with the interval whale optimization algorithm demonstrated competitive performance on validation and test sets. The model achieved high prediction accuracy for glucose, lactate, and viable cell density, with R 2 values exceeding 0.94 and low prediction errors observed on the independent test set. Shapley Additive Explanations and permutation importance analyses indicated that the retained intervals were consistent with chemically plausible vibrational regions. Transfer to a fifth unseen commercial process further demonstrated the applicability limits of the global model and the potential of local updating with limited labeled spectra. The integration of machine learning algorithms and feature selection provides a practical strategy for multiproduct Raman PAT development in commercial biopharmaceutical manufacturing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pharmaceutical Informatics Institute, School of Pharmacy, Zhejiang University, Hangzhou, China.
- BioRay Biopharmaceutical Co., Ltd, Taizhou, China.
ORCID-Profile: Yunfei Shen, Xu Yan, Haibin Qu
Förderung
- the Key Research and Development Program of Zhejiang Province, China
Zitieren
APA
Shen, Y., Wan, Y., Wu, S., Yan, X., Chen, H., Chen, Z., Wang, H., & Qu, H. (2026). Machine Learning‐Enhanced Generic Raman Model for Commercial‐Scale Cell Culture Process Monitoring. Biotechnology Journal. https://doi.org/10.1002/biot.70309
Vancouver
Shen Y, Wan Y, Wu S, Yan X, Chen H, Chen Z, et al. Machine Learning‐Enhanced Generic Raman Model for Commercial‐Scale Cell Culture Process Monitoring. Biotechnology Journal. 2026. doi:10.1002/biot.70309
BibTeX
@article{Shen2026,
author = {Shen, Yunfei and Wan, Yuxiang and Wu, Sijun and Yan, Xu and Chen, Hang and Chen, Zhenhua and Wang, Haibin and Qu, Haibin},
title = {Machine Learning‐Enhanced Generic Raman Model for Commercial‐Scale Cell Culture Process Monitoring},
journal = {Biotechnology Journal},
year = {2026},
doi = {10.1002/biot.70309}
}
EUVIMED